Enhanced pathogenicity of susceptible strains of the Bacteroides fragilis group subjected to low doses of metronidazole

Aldridge, 1995, The occurrence, virulence and antimicrobial resistance of anaerobes in polymicrobial infections, Am. J. Surg, 169, 02 Duerden, 1991, Anaerobes in Human Disease Summanen, 1993 Finegold, 1990, Anaerobes: problems and controversies in bacteriology, infections and susceptibility testing, Rev. Infec. Dis, 12, 223, 10.1093/clinids/12.Supplement_2.S223 Vollaard, 1994, Colonization and resistance, Antimicrob. Agents Chemother, 38, 409, 10.1128/AAC.38.3.409 Tannock, 1998, The normal microflora: new concepts in health promotion, Microbiol. Sci, 5, 4 Freeman, 1997, Metronidazole: a therapeutic review and update, Drugs, 54, 679, 10.2165/00003495-199754050-00003 Lamp, 1999, Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials, Clin. Pharmacokinet, 36, 353, 10.2165/00003088-199936050-00004 Katzung, 1998, Farmacologia Basica e Clinica, 566 Jenks, 1999, Exposure to metronidazole in vivo readily induces resistance in Helicobacter pylori and reduces the efficacy of eradication therapy in mice, Antimicrob. Agents Chemother, 43, 777, 10.1128/AAC.43.4.777 Eisenstadt, 1994, Antibiotic-resistant mutants, 304 Pleasants, 1974, Gnotobiotics, 119 Drabkin, 1932, Spectrophotometric constants for common hemoglobin derivates in human dog and rabbit blood, J. Biol. Chem, 98, 719, 10.1016/S0021-9258(18)76122-X Ferraris, 1992, Regulation of brush-border enzyme activities and enterocyte migration rates in mouse small intestine, Am. J. Physiol, 262, G1047 Arantes, 1997, Distribution of enteroglucagon- and peptide YY-immunoreactive cells in the intestinal mucosa of germ-free and conventional mice, Cell Tissue Res, 290, 61, 10.1007/s004410050908 Coligan, 1994, Preparation of Human Mononuclear Cell Population and Subpopulation, vol. 2, sections 7.1.1 Lima, 2001, Leukotoxic activity of Actinobacillus actinomycetemcomitans isolated from human and non human primates, Braz. J. Microbiol., 32, 250, 10.1590/S1517-83822001000300018 Dubreuil, 1999, Susceptibility testing of anaerobic bacteria: evaluation of the redesigned (version 96) bioMérieux ATB ANA Device, J. Clin. Microbiol, 37, 1824, 10.1128/JCM.37.6.1824-1828.1999 Philips, 2001, Reevaluation of antibiotic breakpoints, Clin. Infect. Dis, 33, S230, 10.1086/321853 Hooper, 1998, Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem, BioEssays, 20, 236, 10.1002/(SICI)1521-1878(199804)20:4<336::AID-BIES10>3.0.CO;2-3 Tabaqchali, 1992, Epidemiological aspects of infections by Bacteroides fragilis and Clostridium difficile, Eur. J. Clin. Microbiol. Infect. Dis, 11, 1049, 10.1007/BF01967798 Diniz, 2000, Effect of metronidazole on the pathogenicity of resistant Bacteroides strains in gnotobiotic mice, Antimicrob. Agents Chemother, 44, 2419, 10.1128/AAC.44.9.2419-2423.2000 Rotstein, 1986, A Bacteroides by-product inhibits human polymorphonuclear leukocyte function, Arch. Surg, 121, 81, 10.1001/archsurg.1986.01400010096012 Rotstein, 1993, Interactions between leukocytes and anaerobic bacteria in polymicrobial surgical infections, Clin. Infect. Dis, 16, S190, 10.1093/clinids/16.Supplement_4.S190 Heimdahl, 1985, Changes in the oropharyngeal and colon microflora in relation to antimicrobial concentrations in saliva and faeces, Scand. J. Infect. Dis. Suppl, 44, 52 2000, Antimicrobial Resistance an Ecological Perspective Ferreira, 1989, Influence of metronidazole, chloramphenicol, clindamycin and penicillin G on growth and neuraminidase activity of Bacteroides fragilis, J. Antimicrob. Chemother, 24, 157, 10.1093/jac/24.2.157 Lorian, 1994, Effect of low antibiotic concentrations on bacteria: effects on ultrastructure, virulence, and susceptibility to immune defenses, 459 Casadevall, 1999, Host–pathogen interactions: redefining the basic concepts of virulence and pathogenicity, Infect. Immun, 67, 3703, 10.1128/IAI.67.8.3703-3713.1999 Lederberg, 1999, Paradoxes of the host–parasite relationship, ASM News, 65, 811 Barret, 1978 Van den Broek, 1989, Antimicrobial drugs, microorganisms and phagocytes, Rev. Infect. Dis, 11, 213, 10.1093/clinids/11.2.213